Newborn screening linked to earlier diagnosis, treatment of SMA

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Mar 13 / Springer Healthcare

Newborn screening linked to earlier diagnosis, treatment of SMA

Neuroscience Spinal Muscular Atrophy MDA-2022

Description

Laurent Servais talks through the findings of a real-world study showing that newborn screening for spinal muscular atrophy is associated with earlier diagnosis and treatment, and better outcomes, when compared with clinical diagnosis.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.